We conclude that AEG-1/MTDH and NF-κB signaling is active in epithelial ovarian cancer, where there appears to be a gradual increase in the expression of these molecules when moving across the spectrum of ovarian carcinogenesis, from borderline ovarian tumours to the frank malignant epithelial carcinomas. This evidence concerns the gene MTDH and ovarian carcinoma.